Clay B Siegall's Net Worth
Clay B Siegall's net worth is estimated to be at least $50,327,388.29 as of 12/24/2024. CoreStreet's estimation of Clay B Siegall's net worth is based on their sale of stock and current holding of stock.
Clay B Siegall is CEO at Immunome Inc. They have executed at least 43 trades of stock as per SEC Form 4 filings. Their most recent trade was for 66,057 units of IMNM stock on 11/21/2024. Their biggest sale was on 12/07/2021 when they sold 45,449 units of Seagen Inc stock for $6,756,448.34. They typically trade 3 times per year.
Total value of insider buys:
- $1,630,179.42
Total value of insider sells:
- $48,697,208.87
Most recent insider trade:
- Nov. 21, 2024
Clay B Siegall's Insider Trading History
| Immunome Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 21, 2024 | CEO | 66,057 | $9.54 | Buy | $630,183.78 |
Oct. 2, 2023 | CEO | 169,204 | $5.91 | Buy | $999,995.64 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 12, 2022 | CEO | 17,043 | $125.69 | Sell | $2,142,134.67 |
April 20, 2022 | CEO | 1,885 | $144.32 | Sell | $272,043.20 |
April 7, 2022 | CEO | 17,043 | $154.23 | Sell | $2,628,541.89 |
March 7, 2022 | CEO | 17,043 | $134.35 | Sell | $2,289,727.05 |
Feb. 7, 2022 | CEO | 17,043 | $139.97 | Sell | $2,385,508.71 |
Jan. 7, 2022 | CEO | 17,044 | $144.73 | Sell | $2,466,778.12 |
Dec. 20, 2021 | CEO | 1,227 | $149.85 | Sell | $183,865.95 |
Dec. 7, 2021 | CEO | 45,449 | $148.66 | Sell | $6,756,448.34 |
Aug. 27, 2021 | CEO | 14,294 | $169.05 | Sell | $2,416,400.70 |
May 5, 2020 | CEO | 24,598 | $166.08 | Sell | $4,085,235.84 |
Oct. 11, 2017 | Insider | 18,832 | $61.18 | Sell | $1,152,141.76 |
April 5, 2017 | Insider | 14,465 | $62.99 | Sell | $911,150.35 |
March 6, 2017 | CEO | 14,465 | $68.04 | Sell | $984,198.60 |
Feb. 6, 2017 | Insider | 14,465 | $61.54 | Sell | $890,176.10 |
June 6, 2016 | CEO | 22,083 | $43.59 | Sell | $962,597.97 |
May 27, 2016 | CEO | 48,660 | $40.41 | Sell | $1,966,350.60 |
May 24, 2016 | CEO | 8,400 | $40.09 | Sell | $336,756.00 |
May 23, 2016 | CEO | 6,700 | $40.12 | Sell | $268,804.00 |
May 17, 2016 | CEO | 7,618 | $35.16 | Sell | $267,848.88 |
April 25, 2016 | CEO | 800 | $40.00 | Sell | $32,000.00 |
April 5, 2016 | CEO | 7,618 | $36.12 | Sell | $275,162.16 |
March 22, 2016 | CEO | 15,236 | $35.52 | Sell | $541,182.72 |
March 21, 2016 | CEO | 4,282 | $35.01 | Sell | $149,912.82 |
Nov. 17, 2015 | CEO | 87,473 | $45.40 | Sell | $3,971,274.20 |
July 6, 2015 | CEO | 3,718 | $46.94 | Sell | $174,522.92 |
June 3, 2015 | CEO | 3,718 | $45.72 | Sell | $169,986.96 |
Jan. 6, 2015 | CEO | 16,804 | $31.80 | Sell | $534,367.20 |
Sept. 4, 2014 | CEO | 5,600 | $42.54 | Sell | $238,224.00 |
Aug. 12, 2014 | CEO | 11,200 | $40.38 | Sell | $452,256.00 |
Aug. 11, 2014 | CEO | 2,700 | $40.05 | Sell | $108,135.00 |
June 10, 2014 | CEO | 11,200 | $40.14 | Sell | $449,568.00 |
Oct. 1, 2013 | CEO | 2,000 | $43.87 | Sell | $87,740.00 |
Sept. 3, 2013 | CEO | 102,000 | $43.90 | Sell | $4,477,800.00 |
Aug. 1, 2013 | CEO | 2,000 | $40.03 | Sell | $80,060.00 |
July 1, 2013 | CEO | 2,000 | $32.59 | Sell | $65,180.00 |
June 3, 2013 | CEO | 2,000 | $33.88 | Sell | $67,760.00 |
Feb. 1, 2013 | CEO | 2,000 | $29.61 | Sell | $59,220.00 |
Nov. 1, 2012 | CEO | 8,250 | $25.51 | Sell | $210,457.50 |
Sept. 4, 2012 | CEO | 8,250 | $26.54 | Sell | $218,955.00 |
| Ultragenyx | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 10, 2020 | Director | 11,346 | $85.01 | Sell | $964,523.46 |
Aug. 7, 2020 | Director | 23,404 | $85.55 | Sell | $2,002,212.20 |